LOS ANGELES and HONG KONG, June 30, 2010 (GLOBE NEWSWIRE) -- Artificial Life, Inc., (OTCBB:ALIF) (http://www.artificial-life.com), a leading provider of award-winning mobile 3G technology and applications, announced today their soon to be launched mobile telemedicine health solution GluCoMo (short for: GluCose Monitor), the first in a series of planned mobile healthcare products.
GluCoMo is a diabetes management solution leveraging Artificial Life's OPUS-M™ platform for end-consumers, healthcare providers and healthcare businesses. GluCoMo is scheduled for commercial availability in July, 2010.
Introducing GluCoMo
The application is a mobile telemedicine and healthcare solution allowing diabetics, caregivers, doctors, and hospitals to share and communicate through mobile mediums such as smartphones, tablets, netbooks and other mobile internet devices. With the facilitation of mobile data sharing and smart back-end processes, the goals are to promote better personal diabetes management habits, increase peace of mind for friends, families and caregivers, and enable remote and real time monitoring and management of patients by doctors and hospitals for advancement in healthcare services and a reduction in administration costs.
GluCoMo is a customized mobile device front-end client and portal as well as a custom back-end infrastructure supported by Artificial Life's m-commerce solution OPUS-M:
Front-end
The GluCoMo front-end is comprised of two parts, a mobile client and web portal. The mobile client is able to support most major smartphone platforms allowing users to keep track of relevant information in real time such as blood sugar levels, calorie intake, personal activities, medication intake and more. Visualization of the data gives users quick snapshots of their medical history. Sharing of information is also simplified and promoted through online social communities and forums so that users can quickly share their latest medical status, diabetic activities and medical information with others. For greater flexibility and convenience, a synchronized web portal is also available for users, their friends, family members and caregivers.
Back-end
The GluCoMo back-end is powered by Artificial Life's OPUS-M technology and allows for friends, families, and caregivers to share critical information and thoughts with each other.
Business Model
The front-end mobile client of GluCoMo will initially be launched as a limited free mobile app and service. Depending on the needs of the users, additional features and functions for the mobile client can then be purchased inside the mobile app in the coming versions.
GluCoMo will soon also be offered as a white label solution and can be adopted by doctors, health clinics, hospitals and/or healthcare industry businesses. The pricing of the customization, integration and maintenance services are based on monthly rental and usage fees.
"Artificial Life further expands its business app portfolio by launching a first and powerful mobile medical solution for diabetics. Other telemedicine products will follow," said Eberhard Schoneburg, CEO of Artificial Life, Inc.
About Artificial Life, Inc.
Artificial Life, Inc. has been a pioneer in artificial intelligence and mobile technology since its inception in Boston in 1994. We are a public US corporation (OTCBB:ALIF) with listing on the Frankfurt Stock Exchange (Frankfurt:AIF) (XETRA:AIF) and headquarters in Hong Kong. Our production center is in Hong Kong and we have additional offices in Berlin, Germany (EMEA headquarters), Los Angeles and Tokyo, Japan. As a leading provider of broadband mobile content and technology solutions in the world, we develop and sell a wide range of mobile games and applications for 3G, 3.5G and 4G network-enabled mobile (smart) phones.
The Artificial Life logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=1669
For more information about Artificial Life, Inc., please visit our website http://www.artificial-life.com">www.artificial-life.com or our product websites: http://www.botme.com">www.botme.com, http://www.mopa-tv.com">www.mopa-tv.com, http://www.opus-m.com">www.opus-m.com and www.green-cortex.com.
Facebook: http://www.botme.com/ref/alife-fb
Twitter: http://twitter.com/alifegames
MySpace: http://www.myspace.com/artificial_life_inc
Youtube: http://www.youtube.com/user/alifegames
Forward-Looking Statements:
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, without limitation, statements regarding our future results of operations, financial condition and business prospects. In some cases, you can identify forward-looking statements by terminology such as "may", "will", "should", "expect", "intend", "plan", "anticipate", "believe", "estimate", "predict", "potential", "continue" or the negative of these terms or other comparable terminology. Although such statements are based on our own information and information from other sources we believe to be reliable, you should not place undue reliance on them. These statements involve risks and uncertainties, and actual market trends or our actual results of operations, financial condition or business prospects may differ materially from those expressed or implied in these forward looking statements for a variety of reasons. Potential risks and uncertainties include, but are not limited to, our ability to obtain additional funding to operate and grow our business; the unproven potential of our mobile gaming business model; changing consumer preferences and uncertainty of market acceptance of our products; timely adoption and availability of 3G mobile technology; market acceptance for use of mobile handheld devices to play the interactive games; unpredictable mobile game development schedules; our reliance on a relatively small number of brands; our ability to license brands from others; our dependence upon resellers and telecommunication carriers and operators to distribute our products; our ability to successfully develop, introduce, and sell new or enhanced products in a timely manner; and the timing of new product announcements or introductions by us or by our competitors. For additional discussion of these risks and uncertainties and other factors, please see the documents we file from time to time with the Securities and Exchange Commission, including our Annual Report on Form 10-KSB filed on March 16, 2010. We assume no obligation to update any forward-looking statements, which apply only as of the date of this press release.